|
| Status |
Public on Jul 30, 2013 |
| Title |
SHAE004_icSARS_12h_2 |
| Sample type |
RNA |
| |
|
| Source name |
SHAE004_icSARS_12h_2
|
| Organism |
Homo sapiens |
| Characteristics |
cell type: Human airway epithelium cells (HAE)
infection code: icSARS
sample material: cells
timepoint: 12h
biological replicate: 2
|
| Treatment protocol |
Cells were seeded in 6-well plates (1 x 10e6 cells/well) two days prior to infection. Immediately preceding infection, cell monolayers were washed with fresh medium and inoculated with either SARS viruses (MOI = 2) or A/CA/04/2009 (MOI = 1) and subsequently incubated at 37°C for 40 minutes. Mock-infected controls were inoculated with culture medium only. Following the incubation, cell monolayers were washed 3X with 1X PBS and fresh medium was added to the wells prior to time 0.
|
| Growth protocol |
Human airway epithelium cultures (HAE) were generated by provision of an air-liquid interface for 6 to 8 weeks to form well-differentiated , polarized cultures that resemble in vivo pseudo-stratified mucociliary epithelium.
|
| Extracted molecule |
total RNA |
| Extraction protocol |
At 0, 12, 24, 36, 48, 60, 72, 84 and 96 hours post-infection (hpi) (SARS viruses) or 0, 6, 12, 18, 24, 36 and 48 hpi (H1N1) triplicate/quadruplicate wells of infected cells or mock infected were washed with 1X PBS and lysed directly with 1 ml of Trizol (Invitrogen) according to the manufacturer’s recommendation. The resulting lysates were stored at -80°C until further processing. All Trizol lysates were processed simultaneously: they were phase-separated, and RNA was isolated from the aqueous phase (diluted 2 fold with RLT buffer) using Qiagen RNeasy Mini columns and the manufacturer’s recommended protocol (Qiagen Inc., Valencia, CA). RNA quality was assessed on an Agilent 2100 Bioanalyzer using the nanochip format, and only intact RNA was used for quantitative PCR (qPCR) and microarray analyses.
|
| Label |
Cy3
|
| Label protocol |
The Agilent One-Color Microarray-Based Gene Expression Analysis Protocol was followed for the Cy3-cDNA probe preparation.
|
| |
|
| Hybridization protocol |
The Agilent One-Color Microarray-Based Gene Expression Analysis Protocol was followed for hybridization and array washing. Two hundred fifty ng of each RNA sample was hybridized to one Agilent 4X44K human HG (Design ID 014850) array.
|
| Scan protocol |
Dry slides were scanned on an Agilent DNA microarray scanner (Model G2505B) using the XDR setting.
|
| Data processing |
Raw images were analyzed using the Agilent Feature Extraction software (version 9.5.3.1) and the GE1-v5_95_Feb07 extraction protocol. All arrays were required to pass Agilent QC flags. Extracted raw data were background corrected using the norm-exp method and quantile normalized using Agi4x44PreProcess and RMA Bioconductor packages.
|
| |
|
| Submission date |
Jun 14, 2013 |
| Last update date |
Jul 31, 2013 |
| Contact name |
Michael Katze |
| E-mail(s) |
[email protected]
|
| Organization name |
University of Washington
|
| Department |
Microbiology
|
| Lab |
Michael G. Katze, Ph.D
|
| Street address |
Rosen Building 960 Republican St.
|
| City |
Seattle |
| State/province |
WA |
| ZIP/Postal code |
98109-4325 |
| Country |
USA |
| |
|
| Platform ID |
GPL6480 |
| Series (2) |
| GSE47962 |
SHAE004: SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
| GSE47963 |
SARS-CoV, SARS-dORF6 and SARS-BatSRBD infection of HAE cultures. |
|
